BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11952535)

  • 1. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds.
    Zhou LH; Nahm WK; Badiavas E; Yufit T; Falanga V
    Br J Dermatol; 2002 Mar; 146(3):365-74. PubMed ID: 11952535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages.
    Ohtani T; Mizuashi M; Ito Y; Aiba S
    Exp Dermatol; 2007 Apr; 16(4):318-23. PubMed ID: 17359338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadexomer-iodine ointment shows stimulation of epidermal regeneration in experimental full-thickness wounds.
    Lamme EN; Gustafsson TO; Middelkoop E
    Arch Dermatol Res; 1998; 290(1-2):18-24. PubMed ID: 9522997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy.
    Akiyama H; Oono T; Saito M; Iwatsuki K
    J Dermatol; 2004 Jul; 31(7):529-34. PubMed ID: 15492416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with cadexomer iodine (Iodosorb) in the treatment of skin ulcers].
    Caccamo RM; Ranno R; Micali G
    Minerva Chir; 1994 Apr; 49(4):349-55. PubMed ID: 8072713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic wounds treated with iodinated cadexomer. Study of a series of clinical cases with Iodosorb].
    Verdú Soriano J
    Rev Enferm; 2010 Nov; 33(11):38-42. PubMed ID: 21188870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadexomer iodine effectively reduces bacterial biofilm in porcine wounds ex vivo and in vivo.
    Roche ED; Woodmansey EJ; Yang Q; Gibson DJ; Zhang H; Schultz GS
    Int Wound J; 2019 Jun; 16(3):674-683. PubMed ID: 30868761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cadexomer Iodine in the Treatment of Chronic Ulcers: A Randomized, Multicenter, Controlled Trial.
    Raju R; Kethavath SN; Sangavarapu SM; Kanjarla P
    Wounds; 2019 Mar; 31(3):85-90. PubMed ID: 30720444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds.
    Mertz PM; Oliveira-Gandia MF; Davis SC
    Dermatol Surg; 1999 Feb; 25(2):89-93. PubMed ID: 10037509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on total microbial load and community composition with two vs six-week topical Cadexomer Iodine for treating chronic biofilm infections in diabetic foot ulcers.
    Malone M; Schwarzer S; Radzieta M; Jeffries T; Walsh A; Dickson HG; Micali G; Jensen SO
    Int Wound J; 2019 Dec; 16(6):1477-1486. PubMed ID: 31487117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics and antiseptics for venous leg ulcers.
    O'Meara S; Al-Kurdi D; Ovington LG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter trial of cadexomer iodine to treat venous stasis ulcer.
    Holloway GA; Johansen KH; Barnes RW; Pierce GE
    West J Med; 1989 Jul; 151(1):35-8. PubMed ID: 2669345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers.
    Skog E; Arnesjö B; Troëng T; Gjöres JE; Bergljung L; Gundersen J; Hallböök T; Hessman Y; Hillström L; Månsson T; Eilard U; Eklöff B; Plate G; Norgren L
    Br J Dermatol; 1983 Jul; 109(1):77-83. PubMed ID: 6344906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wound healing under the effect of iodine cadexomer in rats.
    Brustolin EV; Skare TL; Nassif PA; Biondo-Simões Mde L; Prestes MA; Ozono LM; Ramos CE
    Acta Cir Bras; 2012 Dec; 27(12):874-9. PubMed ID: 23207754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cadexomer iodine on the microbial load and diversity of chronic non-healing diabetic foot ulcers complicated by biofilm in vivo.
    Malone M; Johani K; Jensen SO; Gosbell IB; Dickson HG; McLennan S; Hu H; Vickery K
    J Antimicrob Chemother; 2017 Jul; 72(7):2093-2101. PubMed ID: 28402558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained ability for fibroblast outgrowth from stored neonatal foreskin: a model for studying mechanisms of fibroblast outgrowth.
    Nahm WK; Zhou L; Falanga V
    J Dermatol Sci; 2002 Feb; 28(2):152-8. PubMed ID: 11858954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-patient treatment of chronic varicose venous ulcers. A randomized trial of cadexomer iodine versus standard dressings.
    Laudanska H; Gustavson B
    J Int Med Res; 1988; 16(6):428-35. PubMed ID: 2466712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadexomer iodine provides superior efficacy against bacterial wound biofilms in vitro and in vivo.
    Fitzgerald DJ; Renick PJ; Forrest EC; Tetens SP; Earnest DN; McMillan J; Kiedaisch BM; Shi L; Roche ED
    Wound Repair Regen; 2017 Jan; 25(1):13-24. PubMed ID: 27859922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadexomer iodine (Iodosorb) compared with dextranomer (Debrisan) in the treatment of chronic leg ulcers.
    Tarvainen K
    Acta Chir Scand Suppl; 1988; 544():57-9. PubMed ID: 2459870
    [No Abstract]   [Full Text] [Related]  

  • 20. Cadexomer iodine: an effective palliative dressing in chronic critical limb ischemia.
    Williams RL
    Wounds; 2009 Jan; 21(1):15-28. PubMed ID: 25904581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.